Protein folding stress in the endoplasmic reticulum (ER) may lead to activation of the unfolded protein response (UPR), aimed to restore cellular homeostasis via transcriptional and post-transcriptional mechanisms. ER stress is also reported to activate the ER overload response (EOR), which activates transcription via NF-jB. We previously demonstrated that UPR activation is an early event in pre-tangle neurons in Alzheimer's disease (AD) brain. Misfolded and unfolded proteins are degraded via the ubiquitin proteasome system (UPS) or autophagy. UPR activation is found in AD neurons displaying both early UPS pathology and autophagic pathology. Here we investigate whether activation of the UPR and/or EOR is employed to enhance the proteolytic capacity of neuronal cells. Expression of the immunoproteasome subunits b2i and b5i is increased in AD brain. However, expression of the proteasome subunits is not increased by the UPR or EOR. UPR activation does not relocalize the proteasome or increase overall proteasome activity. Therefore proteasomal degradation is not increased by ER stress. In contrast, UPR activation enhances autophagy and LC3 levels are increased in neurons displaying UPR activation in AD brain. Our data suggest that autophagy is the major degradational pathway following UPR activation in neuronal cells and indicate a connection between UPR activation and autophagic pathology in AD brain.
The Alzheimer's disease (AD) brain is characterized by the accumulation of extracellular plaques composed of Amyloid beta (Ab) and intracellular neurofibrillary tangles (NFTs) composed of hyperphosphorylated tau. 1 We have previously shown that the unfolded protein response (UPR) is activated in AD neurons that contain diffusely distributed hyperphosphorylated tau. 2 The UPR is a stress response that is activated upon the accumulation of misfolded or unfolded proteins in the endoplasmic reticulum (ER). 3, 2 It is aimed at restoring homeostasis by attenuating overall protein translation, and by promoting transcription and translation of specific genes involved in protein homeostasis. Another, less-wellstudied, ER stress response is the ER overload response (EOR), which signals via NF-kB. 4, 5 The degradation of aberrant ER proteins is mediated by a process termed ER-associated degradation (ERAD). 6 Activation of the UPR induces a number of ERAD-related genes. 7 ERAD involves export of the misfolded proteins via specific channels in the ER membrane and subsequent degradation by the cytosolar ubiquitin proteasome system (UPS). 6 The proteasome 20S catalytic core comprises three catalytically active beta (b) type subunits b1, b2 and b5, which convey peptidyl-glutamyl peptide-hydrolyzing-(PGPH), trypsin-and chymotrypsin-like activity. The constitutive b subunits can be exchanged for the immuno subunits b1i, b2i and b5i under the influence of NF-kB signalling, for example during antigen presentation. 8 The immunoproteasome displays slightly altered catalytic activity; for example, it is capable of degrading tau faster and more efficiently in vitro. 9 Changes in proteasome activity are reported for several neurodegenerative disorders, including AD 10, 11 and Parkinson's disease (PD). 12 Systemic administration of proteasome inhibitors in rats causes a PD-like phenotype, with a-synuclein and ubiquitin-positive inclusion bodies and neurodegeneration in the substantia nigra. 12 This suggests that dysfunction of the UPS can lead to neurodegeneration. Interestingly, an increase in the immunoproteasome subunit b1i was observed in the AD brain, 13 a change in proteasome subunit composition that is associated with increased chymotryptic activity. 14, 13 This could be a response to the accumulation of substrates that require a different proteolytic specificity in order to be degraded.
Another major degradational system reported to be activated by ER stress in vitro is autophagy. [15] [16] [17] During autophagy, a double membrane is wrapped around an organelle or protein aggregate and this autophagosome subsequently fuses with a lysosome, forming an autophagolysosome where degradation takes place. Mice deficient in autophagin (atg) 5 18 or atg7 19 accumulate ubiquitin-positive cytoplasmic aggregates and show neurodegeneration. Healthy neurons only rarely show autophagic structures, whereas many autophagic vacuoles can be observed in AD neuronal cell bodies and dystrophic neurites. 20 A commonly observed lesion in the AD brain is granulovacuolar degeneration (GVD), which is considered to be a disturbed autophagic process. 21 It is typically seen in the cytoplasm of the pyramidal neurons of the cornu ammonis (CA) 1 and subiculum of the hippocampus, sites that also show extensive tau pathology. 2 GVD consists of electron-dense granules surrounded by a clear vacuole that measure 2-4 mM in size. The presence of GVD in this region of the hippocampus correlates well with the diagnosis of AD.
The UPR is activated as an early response in neurons in AD and may be a signal to enhance the degradational capacity of the affected neuron. Both the UPS and autophagy have a role in the degradation of aberrant proteins in neurodegenerative disorders and have been implicated in AD. UPR-positive neurons in the AD hippocampus are associated with early UPS pathology, in the form of ubiquitin-positive, p62-negative inclusion bodies, and show autophagic pathology in the form of GVD. 2 Here we investigate the role of these two degradational systems during ER stress in vitro and in human AD brain material. All hypotheses tested in this study are visualized in Figure 8a .
Results
Immunoproteasome subunit expression is increased in the AD brain. Previously we reported that UPR activation is predominantly observed in AD hippocampus.
3,2 Therefore, we evaluated expression of the immunoproteasome subunits b2i and b5i in this region of a cohort of AD and age-matched non-demented controls using immunohistochemistry. Both b2i and b5i expression is seen in AD and control hippocampus in neurons, glial cells and endothelial cells, based on morphological assessment (Figures 1a-l) . Increased b1i reactivity in these cell types in AD and aged hippocampus was previously described. 13 Here we show a granular pattern of b2i reactivity in neurons, the intensity of which increases with Braak stages for neurofibrillary changes. No clear association is observed between b2i immunoreactivity in neurons and the local presence of Ab plaques and neurofibrillary changes (data not shown). A moderate increase in b5i immunoreactivity in neurons is observed in high Braak stages. However, there is a remarkable increase in the number of glial cells that are immunoreactive for b5i in higher Braak stages. Double immunolabelling using b5i and a marker for astrocytes (GFAP) or microglia (Iba1) shows that b5i is expressed in both astrocytes and microglia (Figures 1m and n) . Our data show that expression of the immunoproteasome subunits is increased in the AD hippocampus.
ER
stress: effects on proteasome subunit expression. We next investigated whether UPR activation is responsible for the increased expression of the immunoproteasome in an in vitro model. Differentiated neuronal SK-N-SH cells were treated with increasing concentrations of tunicamycin (Tm) to chemically induce the UPR. No change in mRNA levels of the non-catalytic a subunits HC5 and C7 or the constitutive catalytic b subunits b1, b2 and b5 is observed after induction of ER stress (Figure 2a) . Figure 2b shows that the UPR is active under these conditions, as mRNA levels of the UPR-responsive genes BiP and CHOP are increased 25.0-fold ± 5.5 and 18.8-fold ±2.4, respectively. ER stress increases expression of the immuno subunits b5i (alternative transcript b5i-1: 3.9-fold ± 0.4 and b5i-2: 4.1-fold ± 0.7) and, to a lesser extent, b2i (2.0-fold ±0.3). As a positive control for induction of the immuno b subunits, treatment with gIFN was used (5.9-fold ± 0.6, 132.0-fold ± 22.5 and 576.8-fold ± 81.3 for b2i, b5i-1 and b5i-2, respectively). The UPR-responsive genes are not regulated by gIFN. The b1i subunit is increased by gIFN, but is below the detection limit under control or Tm conditions in our model and is therefore not included in Figure 2a .
In accordance with our quantitative PCR (qPCR) data, gIFN results in increased protein levels of b2i and b5i (B35-fold), but not of b2. We find no regulation of the b2i, b5i and b2 proteins levels by Tm. The increase in BiP levels indicates that the UPR is active under these conditions 3 ( Figure 2 ). To exclude the effects of different kinetics, we extended the Tm treatment to 48 h, but this did not change the outcome (not shown). Combined, we find moderate upregulation of the immunoproteasome subunits b2i and b5i at the mRNA level during ER stress, but this does not lead to a change at the protein level.
ER stress does not affect b2i promoter activity. Most UPR-regulated genes contain ER stress-responsive elements (ERSEs) in their promoter. No ERSEs are found in the immuno b subunit proximal promoters, but all contain a consensus NF-kB site that is expected to be activated by the EOR if it is functional (Figure 3a) . To directly investigate the immunoproteasome b subunit promoter NF-kB responsiveness and the effect of ER stress on promoter activity, we cloned the promoter of b2i upstream of the luciferase gene. The b2i subunit is upregulated in AD postmortem material (Figure 1) , is upregulated by gIFN in our qPCR and western blot experiments ( Figure 2 ) and contains a consensus NF-kB-binding site (Figure 3a ). HEK293 cells were transfected with the b2i promoter-luciferase construct and treated with gIFN or Tm for 16 h. The BiP promoterluciferase construct was used as a control for induction of the UPR. 22 The activity of the b2i promoter is increased (B2-fold) by gIFN, but, as expected, there is no change in BiP promoter activity because it does not contain an NF-kB element (Figure 3b) . Abolishment of the b2i NF-kB-binding site by site-directed mutagenesis prevents gIFN-mediated regulation, demonstrating that the b2i promoter is responsive to NF-kB and that the NF-kB signalling route is functional in this model. In contrast, ER stress induced by Tm has no effect on b2i promoter activity, but does (as expected) increase BiP promoter activity (Figure 3b ). Although b5i promoter responsiveness was not directly investigated, our combined data indicate that expression of the immunoproteasome b subunits is not regulated by the UPR or EOR pathway of the ER stress response.
ER stress has no effect on b5i subunit localization. Several studies indicate enrichment of the immunoproteasome at the ER membrane, 23, 24 which may facilitate rapid degradation of proteins exported out of the ER by ERAD. Relocalization in response to a stimulus may therefore present another level of regulation. We investigated Figure 1 Expression of b2i and b5i immunoproteasome subunits is increased in AD hippocampus. Representative immunohistochemical stainings for b2i (a-f) and b5i (g-l) in the hippocampal CA1 and CA4 region of a non-demented control Braak 1/0 (CA1 (a and g), CA4 (b and h)), AD Braak 3C (CA1 (c and i), CA4 (d and j)) and AD Braak 5C (CA1 (e and k), CA4 (f and l)) case. Reactivity to b2i is present in neurons, glial and endothelial cells, and increases with the Braak stage for NFTs. Double immunolabelling shows b5i expression in astrocytes using GFAP as a marker (m) and microglia using Iba1 as a marker (n) in AD hippocampus. Nuclei were counterstained with hematoxylin (blue). The GFAP/Iba1 and b5i signals were spectrally unmixed and are shown separately (m/n 1 and m/n 2, respectively) and as a merge with artificial colors (m/n 3: GFAP/ Iba1: red; b5i: green). Scale bar: 50 mM localization of the b5i subunit in differentiated SK-N-SH cells during ER stress. Because the great majority of b subunits is incorporated in proteasome complexes, this reflects subunits in actual proteasomes. 25 Cells were double stained using antibodies directed against the b5i proteasome subunit and calnexin, an integral ER membrane protein (Figure 4 ). Reactivity to b5i and its colocalization with calnexin are increased by gIFN, indicating that the increased b5i protein localizes at least in part to the ER membrane. Treatment with Tm does not change the b5i intensity level, confirming our western blot data (Figure 2c ). In addition, the localization of b5i is not affected by activation of the UPR. Although increased immunoreactivity to b2i and b5i is observed in AD, our in vitro studies suggest that UPR activation is not responsible for this induction.
ER stress does not increase proteasome activity. During ER stress, the demand for proteolytic activity is increased. We show that the proteasome b subunits are not subject to classical ER stress responsive regulation (Figures 2 and 3) , nor is relocalization to the ER observed ( Figure 4 ). However, this does not exclude regulation of the proteolytic activity of the proteasome. Using an unstable fluorescent substrate, a small decrease in proteasome activity was previously observed under conditions of ER stress. 26 This reporter system has the disadvantage that it depends on factors besides proteasome activity (e.g. transcription and translation). This method could yield inaccurate results, especially during ER stress, when translation in general is inhibited. To directly investigate the effect of ER stress on total proteasome activity, a fluorescent proteasome activity probe was used that covalently binds to the catalytic subunits of active proteasomes. 27 Differentiated neuronal SK-N-SH cells were treated with Tm and subsequently incubated with the fluorescent reporter, and the fluorescent signal for the different subunits was visualized by SDS-PAGE and quantified (Figures 5a and b) . We find no detectable activity of the immunoproteasome. ER stress has little to no effect on proteasome activity in our cell model. A decrease in activity is observed at the highest concentration of Tm used; however, this might have been caused by Tm-induced toxicity. LC3 processing is increased during ER stress. Our data show that the UPS is not upregulated by the UPR. Because during ER stress there is an increased presence of misfolded proteins, this may lead to accumulation and toxicity if they are not degraded. In contrast to the massive accumulation of polyubiquitinated proteins when using proteasome inhibition, different types of ER stress inducers (Tm, thapsigargin (Th) and 2-deoxyglucose (2DG)) do not lead to accumulation in neuronal cells (Figure 6a , upper panel). This may imply that the proteasome is redundant during ER stress, but it cannot be excluded that basal proteasome activity is still sufficient to deal with the misfolded protein load during ER stress. In case of the latter, complete inhibition of proteasome activity should induce a massive UPR. We have previously demonstrated that proteasome inhibition does not induce a robust ER stress response, 28 suggesting that proteasomal activity is dispensable to resolve ER stress under conditions of UPR activation.
ER stress was previously shown to be able to induce autophagy in vitro. 29, 15 To determine whether ER stress increases autophagy in our cell model, we measured LC3-II levels induced by various ER stressors ( Figure 6a , middle panel). The amount of LC3-II directly correlates with the amount of autophagosomes. 30 Tm, Th and 2DG increase LC3-II levels and the LC3-II/LC3-I ratio (Figure 6b ), indicating that autophagy becomes more active under conditions of ER stress. This suggests that autophagy is the preferred route for degradation of proteins during UPR activation.
LC3 levels are increased in pPERK-positive neurons in the AD brain. The levels of LC3 in AD hippocampus were evaluated using immunohistochemistry. LC3 reactivity is abundant in hippocampal neurons in AD (Figure 7a ) and control subjects (data not shown), whereas low intensity is observed in non-neuronal cells. The intensity of reactivity to LC3 is increased in AD in neurons showing GVD (Figures 7b  and c) . The staining of LC3 is observed throughout the cell body, but appears to be more intense at the edges of the vacuoles, corroborating that GVD is related to autophagosomes. Occasionally, reactivity with the granular material inside the vacuole is observed. We have previously shown that UPR activation is associated with GVD in the AD hippocampus, 3,2 and therefore we used double immunohistochemistry with the UPR marker phosphorylated PERK (pPERK) to investigate the connection between LC3 and UPR activation. LC3 intensity is increased in neurons displaying pPERK reactivity (Figure 7d ). These data show a clear correlation between UPR activation and the autophagy marker LC3 in human AD hippocampus. This corroborates our in vitro data demonstrating that the UPR preferentially activates the autophagy pathway and indicates that this response also occurs in vivo.
Discussion
In this study, we investigated the effects of ER stress on the two major degradational systems in the cell: the UPS and the autophagy pathway, and their relationship with AD ( Figure 8 ).
Increased expression of the immunoproteasome has been found in several neurodegenerative diseases 13, 31, 32 (see also Figure 1 ). Increased expression of b2i and b5i was observed in affected brain areas of Huntington's disease (HD) patients and a mouse model, 31 but could not be recapitulated in a HD cell model, 33 suggesting that a non-cell-autonomous mechanism is responsible for this induction. In analogy, we found that NF-kB is not activated by the EOR in neuronal cells. In the first report on the EOR, retention of a viral protein in the ER induced a robust NF-kB response in HEK293 cells. 4 Another study indicated that chemical ER stress induction also elicits an NF-kB response. 5 However, in our study we found no ER stress-mediated regulation of the NF-kB responsive subunits of the immunoproteasome in HEK293 or neuronal SK-N-SH cells. A small transcriptional response to ER stress was observed; however, this was not sufficient to result in increased protein levels, indicating that the EOR is not effective in our models. We used the endogenous b2i promoter that contains a single NF-kB responsive element, whereas in the previous work a construct containing five NF-kB-binding sites was employed. A small induction of NF-kB may thus lead to increased activity of this reporter, whereas induction of the endogenous b2i promoter will have a higher threshold for transcriptional activation and is unlikely to reach the level required to yield changes at the protein level. In addition, the earlier studies did not investigate the endogenous proteins, as in our study, in which we found a transcriptional response not affecting the protein levels.
Expression of the immunoproteasome in human brain increases with age. 13 Inflammatory markers are increased in the elderly brain, providing support for an immune-mediated increase of the immunoproteasome. 34 In the AD brain a myriad of immune responses can be observed associated with Ab deposits, including activation of complement, increased levels of proinflammatory cytokines (e.g., IL-1b, IL-6 and TNF-a), activated glia and increased NF-kB activation. 35, 36 Our data showed intense b2i immunoreactivity in AD pyramidal neurons, but less for b5i, whereas both subunits were expressed in glial cells. The b5i subunit is encoded within the major histocompatibility class II locus. This locus is transcriptionally less active in neurons, possibly explaining the low b5i expression levels. Although ER stress is not involved in increased expression of the immunoproteasome, this does not rule out a protective effect of the immunoproteasome when it is present. The immunoproteasome is capable of degrading tau more efficiently and with fewer intermediate fragments. 9 Increased immunoproteasome levels may therefore attenuate tau aggregation.
Although total proteasome content is unchanged, decreased proteasome activity has been reported in AD. 10, 11 In contrast, a slight increase in activity was observed when proteasome complexes were purified. 37 Aggregates like Ab can impair proteasome function in vitro 38 and removal of these aggregates by proteasome purification might restore proteasome function. Using a direct assay to study proteasome activity, we demonstrated that UPR activation does not increase proteasome activity in our neuronal SK-N-SH cell model. A moderate decrease in proteasome activity, as measured by the accumulation of a fluorescently labelled UPS substrate, was previously described in MelJuso and Hela cell lines during chemically induced ER stress. 26 As global translation is attenuated during ER stress, our activity probe assay gives a more direct and therefore more reliable result. We also observed a decrease in activity at higher ER stress levels. This may indicate that ER stress contributes to decreased proteasome activity in the AD brain. However, caution is warranted as under these conditions toxic side effects may obscure the data.
Combined, our experiments showed that, in contrast to the increased expression of ERAD components, UPR activation does not enhance proteasomal capacity in vitro. However, ER stress conditions are characterized by the accumulation of proteins in the ER, which need to be degraded in order to ensure cell survival. The observation that ubiquitinated proteins do not accumulate during ER stress suggests that efficient degradation is taking place. We have previously shown that inhibition of the proteasome does not induce a robust ER stress response, as would be expected if the UPS has an essential role in degrading these proteins. 28 This appears to contradict studies showing that proteasome inhibition induces cancer cell apoptosis via ER stress. Dividing cells are dependent on the proteasome for cell cycle progression, and possibly this makes them more susceptible to proteasome inhibition than post-mitotic neuronal cells.
In agreement with other reports, 15, 16 we found that ER stress increases the LC3-II/LC3-I ratio, indicating that autophagy becomes more active. We demonstrated intense LC3 reactivity in pyramidal neurons in both AD and nondemented controls, indicating an important role for autophagy in neurons in the human brain. This is in line with observations showing that levels of LC3-I and LC3-II are high in the mouse brain compared with other tissues. 39 Disruption of autophagy causes the accumulation of polyubiquitinated proteins in neurons in mouse brain. 18, 19 The finding that ubiquitin is involved not only in targeting substrates to the UPS but also in selective autophagy supports this hypothesis.
High LC3 levels might be indicative of a highly active autophagy system and a priming of these cells to deal with misfolded proteins via autophagy. However, our antibody recognized both LC3-I and -II and thus did not give information about the autophagic state in brain. Alternatively, high LC3 levels might be indicative of a disturbed autophagic state, in which LC3 accumulates because it cannot be degraded. In addition to morphological observations of disturbed autophagy in AD, 20 the levels of Beclin-1 are decreased in AD brain; 40 therefore, different lines of evidence point to an impairment of autophagy in AD neurons. Strikingly, we found high LC3 levels in neurons that show disturbed autophagy, demonstrated by the presence of GVD, and had activated the UPR. Our data indicate a direct link between UPR activation, autophagy and the occurrence of autophagic pathology in vivo.
If aberrant proteins accumulate to such extent that the UPR is induced, the ERAD process might be overwhelmed. In addition, higher amounts of misfolded proteins in the ER may more readily form aggregates, which cannot be exported. Under these conditions, bulk degradation of parts of the ER may be a more favorable pathway to restore homeostasis. This hypothesis is supported by the fact that ER stress markers are observed in GVD in AD and that these neurons display high levels of the autophagy marker LC3. It remains elusive whether autophagic pathology arises because the autophagy system becomes overwhelmed or whether, with age for example, the autophagic system becomes less efficient.
Our data support a model in which the proteasome degrades misfolded proteins from the ER, but if this system is overloaded, autophagy is activated. This implies that autophagy is the major degradational pathway during activation of the UPR in neuronal cells. Figure 8 shows a diagram of all hypotheses tested in this study and the final model. As the UPR is activated in neurons in which tau is not aggregated into tangles, this pathway may provide a target for early therapeutic intervention in AD.
Materials and Methods
Cell culture, differentiation and treatment. Human SK-N-SH neuroblastoma and HEK293 cells were cultured in Dulbecco's modified Eagle's medium with GlutaMAX (Gibco BRL, Carlsbad, CA, USA) supplemented with 10% fetal calf serum (Gibco BRL) and 100 U/ml penicillin (Yamanouchi Pharma BV, Leiderdorp, The Netherlands). SK-N-SH cells were differentiated in culture medium supplemented with all trans-retinoic acid (Sigma, St Louis, MO, USA) in a final concentration of 10 mM for 5 days. Differentiated cells were treated with 500 U/ml gIFN (PBL Biomedical Laboratories, Piscataway, NJ, USA), epoxomycin, Tm, Th and 2DG (all from Sigma, USA) at the indicated concentrations for 16 h.
RNA isolation and cDNA synthesis. For RNA isolation, differentiated SK-N-SH cells (5 Â 10 5 per well in a six-well plate) were harvested in TRIzol reagent (Invitrogen, Carlsbad, CA, USA) and total RNA was isolated using the QIAcube (QIAGEN, Venlo, The Netherlands). The protocol was used according to the manufacturer's specifications. RNA concentrations and purity were assessed by OD measurements at 260 and 280 nm on a NanoDrop spectrophotometer (Thermo Scientific, Waltham, MA, USA). For cDNA synthesis, 1 mg of RNA and 125 pmol OligodT12 primer were dissolved in a total of 10 ml H 2 O and incubated at 721C for 10 min. Reverse transcriptase mix was added, consisting of 5 ml 5Â first-strand buffer (Invitrogen), 0.5 ml SuperScript II RNA polymerase (Invitrogen), 10 mM dNTPs and 25 mM MgCl 2 in a total of 15 ml H 2 0. The mixture was incubated at 421C for 1 h, followed by 15 min at 701C. cDNA quality was assessed on 0.8% agarose gel.
Real-time qPCR. Real-time qPCR was performed using the Light Cycler 480 system (Roche Applied Science, Indianapolis, IN, USA). Oligonucleotide primers (Sigma, USA) used for qPCR are listed in Table 1 . Reaction volumes of 5 ml contained cDNA, 0.1 mM Universal Probe Library probe (Roche Applied Science), also listed in Table 1 , 0.4 mM forward primer, 0.4 mM reverse primer and 2.5 ml 2 Â LightCycler 480 Probes Master (Roche Applied Science). After denaturation for 10 min at 951C, amplification was performed using 35 cycles of denaturation (951C for 10 s), followed by annealing (581C for 15 s) and elongation (721C for 15 s).
Results were analyzed using the LightCycler 480 software (Roche Applied Science) version 1.5.
Western blotting. To obtain lysates, differentiated SK-N-SH cells (2 Â 10 5 per well in a 12-well plate) were scraped in ice-cold lysis buffer containing 1% Triton X-100 and protease inhibitor cocktail (Roche Applied Science) in PBS. The lysate (supernatant) was obtained after centrifugation at 12 000 Â g at 41C for 8 min.
Protein concentration was determined with a Bradford protein assay (Bio-Rad Laboratories, Veenendaal, The Netherlands). Equal amounts of protein were analyzed on 8% (BiP, eEF2a), 10% (ubiquitin) 12% (b2, b2i, b5i) or 18% (LC3) SDS-PAGE gels and blotted onto PVDF membrane (Millipore, Billerica, MA, USA) using a semi-dry electro blotting apparatus. Blots were pre-incubated with 5% nonfat dried milk in PBS-T (0.05% Tween-20 in PBS) for 1 h and subsequently incubated at 41C for 16 h with primary antibodies. Membranes were washed 3 Â 10 min in PBS-T and subsequently incubated with species-specific secondary antibodies conjugated to horseradish peroxidase (dilution 1 : 2000, Dako, Glostrup, Denmark). Reactive protein bands were visualized using LumiLightPLUS Western blotting substrate (Roche Applied Science) and a LAS-3000 luminescent image analyzer (Fuji Photo Film (Europe), Kleve, Germany). Results were analyzed using Advanced Image Data Analyzer software (Raytest, Straubenhardt, Germany) version 3.44.035. The primary antibodies and their dilution factors that were used in this study are listed in Table 2 .
Construction of plasmids. The promoter region 500 bp upstream of the transcription start site of the human b2i gene was amplified from human genomic DNA. The promoter sequence was derived from the genomic sequence database at http://www.ensembl.org (NM_002801). Nested PCR was used to maximize the chances of obtaining the correct fragment. The first round of amplification was performed using the primers described in Table 3 . A thermocycler was used to amplify the DNA templates. Reaction volumes of 50 ml contained 1 Â PCR buffer (Stratagene, Santa Clara, CA, USA), 1 mM dNTPs, 2 mM MgCl 2 , 0.25 mM reverse primer, 0.25 mM forward primer, 0.05 U/ml HotFire Taq polymerase (Stratagene) and 20 mg human genomic DNA. The thermocycler protocol consisted of a 5-min denaturation step at 951C; amplification was performed using 35 cycles of denaturation (951C for 45 s), annealing (551C for 1 min) and elongation (721C for 1 min). The final extension was performed at 721C for 8 min. The nested primers used were extended with an XhoI or HindIII endonuclease site (Table 3) . PCR reactions were performed as described above, with the exception of a 1-min denaturing step, in a total reaction volume of 50 ml. The PCR product size was analyzed by agarose gel electrophoresis, sequenced and purified using the High Pure PCR Cleanup Micro Kit (Roche Applied Science). The b2i promoter fragment was digested using the restriction enzymes XhoI and HindIII and subsequently ligated into the pGL3-basic luciferase reporter vector (Promega, Madison, WI, USA). The b2i promoter NF-kB-binding site was abolished by site-directed mutagenesis using the QuickChange Site Directed Mutagenesis kit (Stratagene), according to the manufacturer's protocol. Three guanines, located in the NF-kB consensus site, were substituted by thymidines, rendering the site non-functional. The BiP promoter construct used was previously described. Immunocytochemistry. Differentiated SK-N-SH cells were grown (2 Â 10 5 cells per well in a 12-well plate) on non-coated sterile glass coverslips. Cells were washed in ice-cold PBS and fixed using 4% paraformaldehyde (Sigma, Zwijndrecht, The Netherlands) for 15 min and permeabilized in ice-cold (À201C) methanol (Merck, Darmstadt, Germany) for 5 min. To block antibody non-specific binding, the cells were incubated in blocking buffer (0.1% bovine serum albumin (BSA; Boehringer, Mannheim, Germany) and 0.05% saponine (in PBS-T, Sigma, The Netherlands)) for 30 min at room temperature. Double staining was performed using antibodies directed against b5i and calnexin in blocking buffer at room temperature for 1 h (Table 2) . Glass slides were washed in PBS-T and subsequently incubated with species-specific secondary antibodies labelled with Cy3 or FITC fluorescent label (dilution 1 : 200 in blocking buffer, Jackson Immuno Research, Westgrove, PA, USA) for 1 h. Cells were washed in PBS-T and incubated with diamidino phenylindole (DAPI, dilution 1 : 1000, Sigma, USA) for 5 min. After rinsing in PBS the glass slides were air dried, embedded in vectashield (Vector Laboratories, Burlingame, CA, USA) and mounted onto glass slides. Imaging was performed using a Leica TCS-SP mounted on an inverted microscope (Leica, Solms, Germany) equipped with a digital CCD camera.
In-gel proteasome activity assay. SK-N-SH cells (10 5 cells per well in a 24-well plate) were differentiated for 7 days before incubation for 16 h in the presence or absence of Tm before addition of Me 4 BodipyFL-Ahx 3 Leu 3 VS (Me 4 BodipyFL probe), a close analog of the BodipyFL probe described previously, 27 at a concentration of 500 nM for 5 h, followed by a chase for 1 h with MG132. The in-gel proteasome activity assay was performed essentially as described. 27 In short, cells were lysed in ice-cold lysis buffer and equal amounts of protein were separated on a 12.5% SDS-PAGE gel. In-gel visualization of the labelled subunits was performed in the wet gel slabs directly by using the GFP settings (l ex 480, l em 510) on the Typhoon Variable Mode Imager (Amersham Biosciences, Diegem, Belgium).
Immunohistochemistry. Post-mortem brain material was obtained from the Netherlands Brain Bank (Table 4 ). Informed consent is available for each patient. Sections (5 mm thick) were mounted onto Superfrost plus tissue slides (MenzelGläser, Braunschweig, Germany) and dried overnight at 371C. For all stainings Figure 8 ER stress preferentially activates autophagy in neuronal cells. (a) Diagram showing the pathways investigated in this study by which ER stress may increase the proteolytic capacity of neuronal cells. ER stress could enhance proteolytic degradation by the proteasome by influencing the subunit composition via activation of the EOR. Alternatively, the UPR can be employed to enhance the expression levels of the constitutive subunits. In addition, regulation of the localization or activity of the proteasome may occur. In addition, the UPR may result in activation of autophagy. (b) Our data show that a disturbance of ER homeostasis resulting in activation of the UPR will activate the autophagy pathway. This can be due to a decreased capability to export misfolded proteins from the ER lumen under these conditions or may relate to the inability of the proteasome to degrade aggregated proteins. In AD neurons, decreased proteasomal degradation as well as a disruption in the autophagosomal/lysosomal system may eventually lead to neurodegeneration sections were deparaffinized and subsequently immersed in 0.3% H 2 O 2 in methanol for 30 min to quench endogenous peroxidase activity and washed for 5 min in PBS. Sections were treated with 10 mmol/l, pH 6.0, sodium citrate buffer heated by microwave for 10 min for antigen retrieval and subsequently incubated with primary antibodies at 41C for 16 h. Antibodies (Table 2) were diluted in PBS containing 1% (w/v) BSA (Boehringer). Negative controls for all immunostainings were generated by omission of primary antibodies. Sections were washed 3 Â 10 min with PBS and subsequently incubated with horseradish peroxidase-labelled a mouse/rabbit secondary antibody (Dako REAL EnVision/HRP Rabbit/Mouse, Dako, Hamburg, Germany). Color was developed using 3,3 0 -diaminobenzidine (0.1 mg/ml, 0.02% H 2 O 2 , 10 min; Sigma, USA) as chromogen. Sections were counterstained with hematoxylin and mounted using Depex (BDH Laboratories Supplies, East Grinstead, UK). For double immunohistochemistry with pPERK and LC3, sections were treated as described above to quench endogenous peroxidase activity and incubated with the pPERK antibody diluted in PBS containing 1% BSA at room temperature for 1 h. Sections were washed 3 Â 10 min with PBS and subsequently incubated with horseradish-labelled goat-anti-rabbit secondary antibody (Dako, Germany) for 1 h. Sections were washed 3 Â 10 min with PBS and color was developed using 3,3 0 -diaminobenzidine (0.1 mg/ml, 0.02% H 2 O 2 , 10 min; Sigma, USA) as chromogen. Development time was determined using a single antibody control. Sections were washed with water and subsequently treated with 10 mmol/l pH 6.0 sodium citrate buffer heated by autoclave for 10 min for antigen retrieval. Sections were washed with PBS for 5 min, pre-incubated with normal swine serum (1 : 10 in 5% BSA/PBS, Dako, Germany) for 10 min and incubated with the LC3 antibody at 41C for 16 h. Sections were washed 3 Â 10 min with PBS and incubated with biotinylated swine-anti-rabbit (1 : 300 in 5% BSA/PBS, Dako, Germany) for 1 h. Sections were washed 3 Â 10 min with PBS and incubated with streptavidin horseradish peroxidase (1 : 100 in 5% BSA/PBS, Dako, Germany) for 1 h. Sections were washed 3 Â 10 min with PBS and 1 Â in Tris-HCl buffer (pH 6.8). Color was developed using liquid permanent red (LPR, Dako, Germany). Development time was determined using a single antibody control. Sections were counterstained with hematoxylin and mounted using Aquamount (BDH Laboratories Supplies). A section incubated only with pPERK antibody but developed at the LPR step was used as a cross-reactivity control. Double immunohistochemistry using b5i and GFAP or Iba was performed as described above with minor modifications. Slides were pre-incubated with normal goat serum (1 : 10 in 5% BSA/PBS) and incubated with both primary antibodies overnight at 41C. Sections were washed 3 Â 10 min with PBS and subsequently incubated with horseradish-labelled goatanti-mouse (undiluted, Dako, Germany) and biotinylated goat-anti-rabbit (1 : 100 in 5% BSA/PBS, Dako, Germany) antibodies. Slides were washed 3 Â 10 min in PBS Probe numbers refer to numbers in the Roche universal probe library and incubated with streptavidin horseradish peroxidase (1 : 100 in 5% BSA/PBS, Dako, Germany) for 1 h. Sections were washed 3 Â 10 min in PBS and developed using 3,3 0 -diaminobenzidine as chromogen. Slides were washed in water and in 1 Â Tris-HCl buffer before developing with LPR. Sections were counterstained with hematoxylin and mounted using Aquamount. We used the Nuance spectral imaging system (CRi, Woburn, MA, USA) to analyze the double-stained sections. Spectral libraries of single-brown (DAB), single-red (LPR) and hematoxylin were obtained from control sections. The spectral library was used to unmix the different reactions products in the double-stained sections into black and white images. These images represent the localization of each of the reaction products and were reverted to fluorescence-like images composed of pseudo-colors by the Nuance software. 
